Impacted health status | Sensitivity | YLD (UI 95%) | DALYs (UI) |
---|---|---|---|
Moderate - Community cases | Increase by 10% | 256 (170–361) | 5484 (5399 - 5589) |
Increase by 25% | 267 (178–377) | 5495 (5406 - 5606) | |
Increase by 50% | 286 (190–405) | 5514 (5418 - 5633) | |
Post-acute consequences for all cases | Transition probability of 26.6% | 406 (272–571) | 5634 (5501 - 5800) |
Transition probability of 6.65% | 171 (113–241) | 5399 (5342 - 5470) | |
Duration of 56 days | 406 (272–571) | 5634 (5501 - 5800) | |
Duration of 14 days | 171 (114–241) | 5399 (5342 - 5470) | |
Post-acute consequences for symptomatic cases only | Transition probability of 26.6% | 275 (184–388) | 5504 (5413 - 5617) |
Transition probability of 6.65% | 138 (92–195) | 5367 (5320 - 5424) | |
Duration of 56 days | 275 (184–388) | 5504 (5413 - 5617) | |
Duration of 14 days | 138 (92–195) | 5367 (5320 - 5424) | |
Combination to minimize the impact of YLD | No increse in Moderate case | 115 (76–163) | 5344 (5305 - 5392) |
Transition to post-acute consequences for symptomatic only | |||
Half the transition of acute to post consequences (6.65%) | |||
Half the duration for post-acute consequences (14 days) | |||
Combination to maximize the impact of YLD | Increase Moderate cases by 50% | 3606 (2295 - 5201) | 8834 (7524 - 10,429) |
Transition to post-acute for All cases | |||
Double transition of acute to post consequences (26.6%) | |||
Double duration for post-acute consequences (56 days) |